Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
LR

Li Ren — 44 Patents

ABArray Biopharma: 32 patents #13 of 335Top 4%
Genentech: 10 patents #288 of 2,392Top 15%
Pfizer: 3 patents #1,614 of 5,153Top 35%
Eli Lilly: 1 patents #1,752 of 2,858Top 65%
SPSion Power: 1 patents #68 of 93Top 75%
CECelularity: 1 patents #20 of 45Top 45%
SRScripps Research: 1 patents #709 of 1,293Top 55%
Indianapolis, IN: #60 of 5,011 inventorsTop 2%
Indiana: #389 of 33,936 inventorsTop 2%
Overall (All Time): #66,838 of 4,157,543Top 2%
44 Patents All Time
Li Ren has been granted 44 US patents while listed as an inventor at Array Biopharma. The first was granted in 2012 and the most recent in July 2025. Li Ren ranks #66,838 of 4,157,543 US inventors in our database (top 1.6%). Patent records list Li Ren in Indianapolis, IN, US.

Issued Patents All Time

Showing 1–25 of 44 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12351571 Substituted quinoxaline compounds as inhibitors of FGFR tyrosine kinases James F. Blake, David A. Moreno, Shane M. Walls 2025-07-08
12303509 Compounds for the treatment of BRAF-associated diseases and disorders Patrick Michael DOERNER BARBOUR, Tanna Bettendorf, Dean Russell Kahn, Alex Andrew KELLUM, Ellen Laird +1 more 2025-05-20
12298280 Method for increasing number of proteins identified by mass spectrometry Congcong Ma, Jin Zhao, Xubo Yuan, Liangyu CHEN, Lei Song +1 more 2025-05-13
12240846 5- and 6-azaindole compounds for inhibition of Bcr-Abl tyrosine kinases Joseph P. Lyssikatos, Samuel Kintz 2025-03-04
12180207 Substituted pyrazolo[1,5-a]pyridine compounds as inhibitors of FGFR tyrosine kinases James F. Blake, David A. Moreno, Tony P. Tang, Shane M. Walls 2024-12-31
12113208 Protective membrane for electrochemical cells Veronika G. Viner, David L. Coleman, Michael G. Laramie, Yuriy V. Mikhaylik, Holger Schneider +4 more 2024-10-08
11998545 Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors Steven W. Andrews, Sean Aronow, James F. Blake, Barbara J. Brandhuber, Adam Cook +9 more 2024-06-04
11964988 Fused heterocyclic compounds as RET kinase inhibitors James F. Blake, Donghua Dai, Julia Haas, Yutong Jiang, Dean Russell Kahn +9 more 2024-04-23
11851434 Substituted pyrazolo[1,5-A]pyrazine compounds as ret kinase inhibitors Steven W. Andrews, James F. Blake, Julia Haas, Yutong Jiang, Gabrielle R. Kolakowski +2 more 2023-12-26
11807638 5- and 6-azaindole compounds for inhibition of Bcr-Abl tyrosine kinases Joseph P. Lyssikatos, Samuel Kintz 2023-11-07
11807649 Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2 Joseph P. Lyssikatos, Samuel Kintz, Qiang Su 2023-11-07 $7,128,000
11802127 3,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-diones as MEK inhibitors Shelley Allen, Patrick Michael DOERNER BARBOUR, James F. Blake, Mark Laurence Boys, Joshua Ryan Dahlke +3 more 2023-10-31 $284,263,000
11767321 5- and 6-azaindole compounds for inhibition of BCR-ABL tyrosine kinases Joseph P. Lyssikatos, Samuel Kintz 2023-09-26
11691973 3,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-diones as MEK inhibitors Shelley Allen, Patrick Michael DOERNER BARBOUR, James F. Blake, Sydney Taylor BLANCHE, Mark Laurence Boys +9 more 2023-07-04
11648243 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Steven W. Andrews, Sean Aronow, James F. Blake, Barbara J. Brandhuber, James Collier +12 more 2023-05-16
11634409 Compounds for the treatment of BRAF-associated diseases and disorders Patrick Barbour, Katie Keaton BROWN, Adam Cook, Erik James Hicken, Dean Russell Kahn +7 more 2023-04-25
11603374 Substituted pyrrolo[2,3-d]pyrimidines compounds as ret kinase inhibitors James F. Blake, Donghua Dai, Julia Haas, Yutong Jiang, Gabrielle R. Kolakowski +6 more 2023-03-14
11524963 Substituted pyrazolo[3,4-d]pyrimidines as RET kinase inhibitors James F. Blake, Donghua Dai, Julia Haas, Yutong Jiang, Gabrielle R. Kolakowski +3 more 2022-12-13
11472802 Substituted pyrazolyl[4,3-c]pyridine compounds as RET kinase inhibitors Shane M. Walls, Ginelle A. Ramann, David A. Moreno, Andrew T. Metcalf, Elizabeth A. McFaddin +6 more 2022-10-18
11414404 Compounds for the treatment of BRAF-associated diseases and disorders Patrick Barbour, Katie Keaton BROWN, Adam Cook, Erik James Hicken, Dean Russell Kahn +7 more 2022-08-16
11168090 Substituted pyrazolo[1,5-a]pyrazines as RET kinase inhibitors Steven W. Andrews, James F. Blake, Julia Haas, Yutong Jiang, Gabrielle R. Kolakowski +2 more 2021-11-09
10953005 Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors Steven W. Andrews, Sean Aronow, James F. Blake, Barbara J. Brandhuber, Adam Cook +9 more 2021-03-23
10934345 Broadly neutralizing antibodies against HIV-1 and use thereof Yiming Shao, Jiang Zhu, Yuxing Li, Ian A. Wilson, Leopold Kong +4 more 2021-03-02
10881652 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Steven W. Andrews, Sean Aronow, James F. Blake, Barbara J. Brandhuber, James Collier +12 more 2021-01-05
10766881 2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases Steven W. Andrews, James F. Blake, Adam Cook, Indrani W. Gunawardana, Kevin W. Hunt +3 more 2020-09-08